The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
05/31/2012
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Description of Modification
Due to extreme weather conditions experienced within the last week, the closing date for receipt of pre-applications is extended until July 5, 2012.
Document Type:
Modification to Previous
Grants Notice
Funding Opportunity Number:
W81XWH-12-SCIRP-IIRA
Opportunity Category:
Discretionary
Posted Date:
May 31, 2012
Creation Date:
Jul 03, 2012
Original Closing Date for Applications:
Oct 01, 2012
Current Closing Date for Applications:
Oct 01, 2012
Archive Date:
Oct 31, 2012
Funding Instrument Type:
Cooperative Agreement
Grant
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
3
Estimated Total Program Funding:
$1,920,000
Award Ceiling:
$0
Award Floor:
$0
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
The SCIRP Investigator-Initiated Research Award (IIRA) mechanism was first offered in FY09. Since then, 132 Investigator-Initiated Research Award applications have been received, and 25 have been recommended for funding.
The IIRA is intended to support studies that have the potential to make an important contribution to SCI research and/or patient care. Projects should be innovative, address an Area of Encouragement, and impact the health care needs of military Service members, Veterans, and/or their family members and caregivers. All applications must specifically and clearly address the military relevance of the proposed research. Collaboration with military researchers and clinicians is encouraged.
Research projects may focus on any phase of research from basic through translational, including preclinical studies in animal models or human subjects, as well as correlative studies associated with an existing clinical trial. Observations that drive a research idea may be derived from laboratory discovery, population-based studies, a clinician’s first-hand knowledge of patients, or anecdotal data.
Applications must include preliminary data that is relevant to SCI and the proposed project.
Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this funding opportunity. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested with a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. For more information on clinical trials and clinical research, a Human Subject Resource Document is provided on the CDMRP eReceipt System at https://cdmrp.org/Program_Announcements_and_Forms/. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the FY12 SCIRP Clinical Trial Award mechanism (Funding Opportunity Number: W81XWH-12-SCIRP-CTA).
Link to Additional Information
If you have difficulty accessing the full announcement
electronically, please contact:
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.
